Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life (Q33658933)

28 July 2017

title

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life (English)

1 reference

28 July 2017

0 references

0 references

1

Antonio W Zuardi

1 reference

Francisco Silveira Guimarães

28 July 2017

6

object named as

Francisco S Guimarães

1 reference

Jaime Eduardo Cecilio Hallak

28 July 2017

5

object named as

Jaime E C Hallak

1 reference

José Alexandre de Souza Crippa

28 July 2017

7

object named as

José A S Crippa

1 reference

28 July 2017

Natália P Rodrigues

2

1 reference

28 July 2017

Angélica L Silva

3

1 reference

28 July 2017

Sandra A Bernardo

4

1 reference

28 July 2017

publication date

11 May 2017

1 reference

Frontiers in Pharmacology

28 July 2017

published in

1 reference

28 July 2017

volume

8

1 reference

28 July 2017

page(s)

259

1 reference

Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

The German guidelines for the treatment of anxiety disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Cannabidiol in humans-the quest for therapeutic targets

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Human experimental anxiety: actual public speaking induces more intense physiological responses than simulated public speaking

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Cannabidiol in inflammatory bowel diseases: a brief overview

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Safety and side effects of cannabidiol, a Cannabis sativa constituent

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Cannabidiol for the treatment of psychosis in Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Agonistic properties of cannabidiol at 5-HT1a receptors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Effects of cannabidiol (CBD) on regional cerebral blood flow

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Pharmacology of human experimental anxiety

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Effect of d-fenfluramine on human experimental anxiety

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Anxiety induced by simulated public speaking and stroop color word test in healthy subjects: effects of different trait-anxiety levels

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Cardiovascular responses to behavioral stressors: laboratory-field generalization and inter-task consistency.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Antianxiety effect of cannabidiol in the elevated plus-maze

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition

21 June 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Effects of gabapentin on anxiety induced by simulated public speaking.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Reprint of "Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)".

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Subjective and neurovegetative changes in healthy volunteers and panic patients performing simulated public speaking

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3389/FPHAR.2017.00259

Therapeutical use of the cannabinoids in psychiatry

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5425583

Effects of ipsapirone and cannabidiol on human experimental anxiety

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28553229

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28553229

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of cannabidiol in animal models predictive of antipsychotic activity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28553229

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3389/FPHAR.2017.00259

1 reference

28 July 2017

1 reference

28 July 2017

1 reference